BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 15154643)

  • 1. The dissociated expression of protein and messenger RNA of DPC4 in human invasive ductal carcinoma of the pancreas and their implication for patient outcome.
    Toga T; Nio Y; Hashimoto K; Higami T; Maruyama R
    Anticancer Res; 2004; 24(2C):1173-8. PubMed ID: 15154643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical expression of receptor-tyrosine kinase c-kit protein and TGF-beta1 in invasive ductal carcinoma of the pancreas.
    Nio Y; Omori H; Hashimoto K; Itakura M; Koike M; Yano S; Toga T; Higami T; Maruyama R
    Anticancer Res; 2005; 25(5):3523-9. PubMed ID: 16101174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biologically different subgroups of invasive ductal carcinoma of the pancreas: Dpc4 status according to the ratio of intraductal carcinoma components.
    Takahashi H; Oda T; Hasebe T; Aoyagi Y; Kinoshita T; Konishi M; Nakagohri T; Inoue K; Takahashi S; Kawahira H; Monden M; Ochiai A
    Clin Cancer Res; 2004 Jun; 10(11):3772-9. PubMed ID: 15173084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of p21(WAF1/CIP1) is an early event in the development of pancreatic intraepithelial neoplasia.
    Biankin AV; Kench JG; Morey AL; Lee CS; Biankin SA; Head DR; Hugh TB; Henshall SM; Sutherland RL
    Cancer Res; 2001 Dec; 61(24):8830-7. PubMed ID: 11751405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Alterations of DPC4/SMAD4/MADH4 gene detected in paraffin-embedded tissues of human pancreatic carcinomas].
    Gu LJ; Chen J; Liu TH; Cui QC; Lu ZH; Li L; Gao J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Apr; 24(2):165-9. PubMed ID: 12905795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic intraepithelial neoplasia and infiltrating adenocarcinoma: analysis of progression and recurrence by DPC4 immunohistochemical labeling.
    McCarthy DM; Brat DJ; Wilentz RE; Yeo CJ; Cameron JL; Kern SE; Hruban RH
    Hum Pathol; 2001 Jun; 32(6):638-42. PubMed ID: 11431719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological significance of abnormalities in Gadd45 expression and its relationship to p53 in human pancreatic cancer.
    Yamasawa K; Nio Y; Dong M; Yamaguchi K; Itakura M
    Clin Cancer Res; 2002 Aug; 8(8):2563-9. PubMed ID: 12171884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of retinoblastoma and p53 pathway-related proteins in resectable invasive ductal carcinoma of the pancreas: potential cooperative effects on clinical outcome.
    Hashimoto K; Nio Y; Koike M; Itakura M; Yano S; Higami T; Maruyama R
    Anticancer Res; 2005; 25(2B):1361-8. PubMed ID: 15865092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 expression affects the efficacy of adjuvant chemotherapy after resection of invasive ductal carcinoma of the pancreas.
    Nio Y; Dong M; Uegaki K; Hirahara N; Minari Y; Sasaki S; Takamura M; Iguchi C; Tamura K
    Anticancer Res; 1998; 18(5B):3773-9. PubMed ID: 9854494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between loss expression of DPC4/Smad4 gene and carcinogenesis of pancreatobiliary carcinoma.
    Tang ZH; Zou SQ; Hao YH; Wang BJ; Yang XP; Chen QQ; Qiu FZ
    Hepatobiliary Pancreat Dis Int; 2002 Nov; 1(4):624-9. PubMed ID: 14607700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of DPC4/Smad4, p21wafI, and p16 in human pancreatic cancer].
    Gu LJ; Chen J; Lu ZH; Li L; Zhou WX; Luo YF
    Ai Zheng; 2002 Feb; 21(2):132-7. PubMed ID: 12479060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SPARC mRNA expression as a prognostic marker for pancreatic adenocarcinoma patients.
    Miyoshi K; Sato N; Ohuchida K; Mizumoto K; Tanaka M
    Anticancer Res; 2010 Mar; 30(3):867-71. PubMed ID: 20393008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of c-kit protein expression in pancreatic neoplasms and its implication for prognosis.
    Kimura W; Ma J; Takeshita A; Yamamoto T; Moriya T; Hirai I; Fuse A
    Hepatogastroenterology; 2007 Dec; 54(80):2203-8. PubMed ID: 18265633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MUC1 overexpression is the most reliable marker of invasive carcinoma in intraductal papillary-mucinous tumor (IPMT).
    Ueda M; Miura Y; Kunihiro O; Ishikawa T; Ichikawa Y; Endo I; Sekido H; Togo S; Shimada H
    Hepatogastroenterology; 2005; 52(62):398-403. PubMed ID: 15816444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemically detected expression of 3 major genes (CDKN2A/p16, TP53, and SMAD4/DPC4) strongly predicts survival in patients with resectable pancreatic cancer.
    Oshima M; Okano K; Muraki S; Haba R; Maeba T; Suzuki Y; Yachida S
    Ann Surg; 2013 Aug; 258(2):336-46. PubMed ID: 23470568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression.
    Wilentz RE; Iacobuzio-Donahue CA; Argani P; McCarthy DM; Parsons JL; Yeo CJ; Kern SE; Hruban RH
    Cancer Res; 2000 Apr; 60(7):2002-6. PubMed ID: 10766191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dpc-4 protein is expressed in virtually all human intraductal papillary mucinous neoplasms of the pancreas: comparison with conventional ductal adenocarcinomas.
    Iacobuzio-Donahue CA; Klimstra DS; Adsay NV; Wilentz RE; Argani P; Sohn TA; Yeo CJ; Cameron JL; Kern SE; Hruban RH
    Am J Pathol; 2000 Sep; 157(3):755-61. PubMed ID: 10980115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical labeling for the Dpc4 gene product is a specific marker for adenocarcinoma in biopsy specimens of the pancreas and bile duct.
    Tascilar M; Offerhaus GJ; Altink R; Argani P; Sohn TA; Yeo CJ; Cameron JL; Goggins M; Hruban RH; Wilentz RE
    Am J Clin Pathol; 2001 Dec; 116(6):831-7. PubMed ID: 11764071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DPC4/Smad4 expression and outcome in pancreatic ductal adenocarcinoma.
    Biankin AV; Morey AL; Lee CS; Kench JG; Biankin SA; Hook HC; Head DR; Hugh TB; Sutherland RL; Henshall SM
    J Clin Oncol; 2002 Dec; 20(23):4531-42. PubMed ID: 12454109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ampulla of vater cancers: T-stage and histological subtype but not Dpc4 expression predict prognosis.
    Beghelli S; Orlandini S; Moore PS; Talamini G; Capelli P; Zamboni G; Falconi M; Scarpa A
    Virchows Arch; 2002 Jul; 441(1):19-24. PubMed ID: 12111196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.